Ketamine 50mg/ml Injectable Vial Recalled for Sterility Concerns
Pharmacy Innovations is recalling Ketamine 50mg/ml injectable vials nationwide due to insanitary facility conditions that compromised sterility assurance.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Per the severity rubric, this recall qualifies as High because it involves a risk-of-harm product (an injectable with compromised sterility assurance) where injury has not yet been reported. Sterility failure in parenteral drugs poses significant potential for serious infection-related harm.
Plain-English summary
Pharmacy Innovations is recalling Ketamine 50mg/ml (10ml vial) Injectable (Rx only) nationwide due to a lack of assurance of sterility. FDA inspection revealed insanitary conditions at the manufacturing facility in Erie, PA that could compromise the sterility of the product.
The recalled product is identified by lot code t20221031@55. The product was distributed nationwide in the USA. Individuals currently using this medication should consult with their healthcare provider regarding their treatment.
The recalled product
- Product
- KETAMINE 50MG/ML (10ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
- Manufacturer
- Pharmacy Innovations
- Category
- Drug — Injectable Drug
- Hazard
- lack-of-sterility
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- t20221031@55
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27